SEATTLE, WA , Dec. 08, 2017 (GLOBE NEWSWIRE) -- CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Medical Marijuana Inc.'s (OTC Pink: MJNA) recent expansion of operations in Europe and how the company has emerged as one of the only global leaders in the cannabidiol (CBD) supplement market.

Expansion into Europe

Medical Marijuana Inc. recently announced that its Kannaway® subsidiary has expanded its business into the European market. Using European-sourced materials, the company has created a distribution network for its organic food products that is capable of distribution to all citizens of the European Union as well as other countries outside of the EU. Management believes that the market will be very amenable to Kannaway’s® direct selling strategies.

Also see: How to Capitalize on the $1 Billion Hemp Industry

“We are extremely excited to take this next step in our international expansion by becoming the first direct selling company to feature phytocannabinoid based products in Europe and to share our products, culture, and mission throughout Europe,” said Medical Marijuana Inc. COO Blake Schroeder. “We have always planned to bring our revolutionary products to a worldwide audience, and Europe is the perfect next step for our company.”

Kannaway® is a network sales and marketing company that specializes in hemp-based botanical products. Through weekly online sales meetings and conferences, the company offers unique insights and opportunities to sales professionals. According to the Worldwide Federation of Direct Selling Associations, European direct sales companies generated more than $35 billion in retail sales in 2015, which points to a significant market opportunity.

Existing Global Presence

Medical Marijuana Inc.’s HempMeds business has made significant inroads into many international markets, particularly in Latin America. After several Latin American countries relaxed laws surrounding cannabinoids, the company has been quick to introduce its hemp-based CBD products through proper regulatory channels. The initial win in Mexico was soon joined by wins in countries like Brazil and U.S. territories like Puerto Rico.

Also see: Latin America Embraces Hemp-based CBD Oil

In February 2016, Mexico’s regulatory authority, COFEPRIS, approved the legal import of Real Scientific Hemp Oil-X™ for two young girls suffering from severe epilepsy and the program has expanded into several other medical conditions since then. Brazil later approved the import of Real Scientific Hemp Oil™ through HempMeds Brasil - an affiliate of Medical Marijuana Inc. - for epilepsy, Parkinson’s disease, and chronic pain indications.

Medical Marijuana Inc. has also committed to undergoing clinical trials in other countries to support the use of CBD-based hemp oil. In fact, a recent clinical study in Mexico confirmed the safety and effectiveness of RSHO-X 5000 for the treatment of Lennox Gastaut Syndrome. The study found an 84% reduction in motor seizures with more than half of patients reporting a better than 75% reduction in seizures and 17% reporting a complete remission.

Please follow the link to read the full article: http://www.cannabisfn.com/medical-marijuana-inc-expands-across-european-union/

Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed. 

About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit http://www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.'s video statement, click here. 

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

Disclaimer:

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/. 

CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com